We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Phuoc Tran

Phuoc T Tran MD

Professor, Radiation Oncology and Molecular Radiation Sciences, Oncology and Urology, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, Maryland

Phuoc T. Tran, MD, PhD, is a Professor of Radiation Oncology and Molecular Radiation Sciences at Johns Hopkins University. He is co-Director of the Program in Cancer Invasion and Metastasis in the Sidney Kimmel Comprehensive Cancer Center and has co-appointments in Medical Oncology, the James Buchanan Brady Urological Institute and the Cellular and Molecular Medicine Program. Phuoc is a board-certified radiation oncologist and clinically specializes in treatment of genitourinary (GU) malignancies.  His research program has been continuously funded by the NIH-DoD and foundations for a decade to focus on tumor cell epithelial plasticity programs and novel agents to enhance the local and systemic effects of radiation.  He also leads an active clinical trials program that includes interventional and translational investigator-initiated studies. He is currently the PI of the first investigator initiated clinical trial examining the next generation AR-antagonist enzalutamide as a radiosensitizer for men with biochemical failure following surgery - SALV-ENZA.  He is the NRG Oncology GU Translational Science chair, RSNA R&E Nominating Committee Member at Large, ASTRO Science Council Research Grants Subcommittee chair and a NCI RTB study section member.

Phuoc received his undergraduate degree at UCSD and his MD and PhD degrees at Oregon Health and Science University. He then completed radiation oncology residency and postdoctoral fellowship at Stanford. Phuoc’s graduate and postdoctoral work focused on DNA repair, cancer biology, and transgenic mouse models. He subsequently joined the faculty of Johns Hopkins University where he served as Clinical Director from 2015-2017 in the department of Radiation Oncology and Molecular Radiation Sciences . He has received numerous awards for his research and clinical work from the RSNA, ASTRO, the Sidney Kimmel Foundation, the American Cancer Society, Uniting Against Lung Cancer, American Lung Association, the Movember Foundation, the Prostate Cancer Foundation and was voted a Top Doctor in Baltimore Magazine. He also serves as a Senior Editor/Editorial Board member for Cancer Research and the Journal of Clinical Oncology.

Disclosures

Dr. Tran discloses the following:
Consulting:
  • RefleXion Medical Inc & Noxopharm
IP:
  • Natsar Pharm
Funding sources:
  • Astellas Pharm, Bayer Healthcare, Asclepix Therapeutics, & RefleXion Medical Inc
  • NIH (U01CA212007, U01CA231776 & R21CA223403)
  • PCF, Movember, Nesbitt-McMaster Foundation, Ronald Rose & Joan Lazar, Barabara’s Fund, National Capitol Cancer Research Fund